Sangamo Therapeutics Inc (NASDAQ:SGMO)

22.25
Delayed Data
As of 4:00pm ET
 -1.05 / -4.51%
Today’s Change
3.65
Today|||52-Week Range
23.90
+35.67%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2016
Quarter 1
2017
Quarter 2
2017
Quarter 3
2017
Revenue and IncomeNet Revenues8.9M3.4M8.3M11.8M
 
 
 
 
 
Depreciation And Amortization252.0K301.0K317.0K412.0K
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses18.5M19.9M20.7M24.4M
 
 
 
 
 
Research And Development13.9M12.9M15.0M18.4M
 
 
 
 
 
Total Operating Expenses18.8M20.2M21.0M24.8M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-9.8M-16.8M-12.8M-13.0M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-9.6M-16.6M-12.5M-12.4M
 
 
 
 
 
Income Taxes-13.0K0.000.000.00
 
 
Net Income-9.6M-16.6M-12.5M-12.4M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS70.7M71.0M72.5M83.8M
 
 
 
 
 
Shares To Calculate EPS Diluted70.7M71.0M72.5M83.8M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.14-$0.23-$0.17-$0.15
 
 
 
 
 
EPS Diluted-$0.14-$0.23-$0.17-$0.15